Vimentin Is a Dominant Target of In Situ Humoral Immunity in Human Lupus Tubulointerstitial Nephritis

A. J. Kinloch, Anthony Chang, Kichul Ko, +12

Arthritis & Rheumatology

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

Rebecca Abraham, Madeleine S. Durkee, Junting Ai, +9

Journal of Clinical Investigation

Glomerular DiseaseEngineeringRenal PathologyImmunologyRenal Inflammation +31

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations

Shruti Sharma, Zhongbo Jin, Elizabeth Rosenzweig, +3

Journal of Autoimmunity

Allelic VariantAutoimmune DiseaseDifferent Ancestral BackgroundsImmune Cell DevelopmentGenetics +11

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients

Kichul Ko, Yelena Koldobskaya, Elizabeth Rosenzweig, +1

Frontiers in Immunology

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection

Yuta Asano, Joe Daccache, Dharmendra Jain, +12

Nature Communications

The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings.

James Merlino, Kichul Ko, Anthony Minotti, +1

PubMed

DiagnosisParathyroid DiseaseParathyroid GlandFalse NegativeFalse Negative Rate +15

The False Negative Technetium-99m-Sestatnibi Scan in Patients with Primary Hyperparathyroidism: Correlation with Clinical Factors and Operative Findings

James Merlino, Kichul Ko, Anthony Minotti, +1

The American Surgeon

Surgical OncologyDiagnosisPathologyParathyroid DiseaseParathyroid Gland +18

Genetic Ancestry, Serum Interferon-α Activity, and Autoantibodies in Systemic Lupus Erythematosus

Kichul Ko, Beverly S. Franek, Miranda C. Marion, +4

The Journal of Rheumatology

Bcl‐2 as a Therapeutic Target in Human Tubulointerstitial Inflammation

Kichul Ko, Jianing Wang, Stuart J. Perper, +13

Arthritis & Rheumatology

Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial

Eliza F. Chakravarty, Tammy O. Utset, Diane L. Kamen, +24

The Lancet Rheumatology

Mycophenolate Mofetil WithdrawalSystemic Lupus ErythematosusLupusLupus NephritisPharmacology +1